Interferon alfa-2b biosimilar (CIGB/Heber Biotec)

干扰素α-2b生物类似药（CIGB/Heber Biotec）

Report date: 2022/02/21 14:20:18

Base Information

Drug NameInterferon alfa-2b biosimilar (CIGB/Heber Biotec)
Drug Alias NameInterferon Alfa-2B (CIGB/Heber Biotec)干扰素α-2b生物仿制药（CIGB/Heber Biotec）InrecHeberon Alfa R
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsVirus Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCuba
Original Approved Date2000/12/01
Country/TerritoryUruguayCuba
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesHeber Biotec
Inactive CompaniesN/A
Active IndicationsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A